A recent report from India’s drug regulatory body has raised alarming concerns as more than 50 commonly used medicines, including supplements for calcium and Vitamin D3, diabetes medications, and blood pressure pills, have failed quality control tests. These drugs, which are supposed to provide essential treatment, have been flagged for not meeting standards, further highlighting an ongoing issue of adulteration in pharmaceutical products. The question that now looms large is: how has this problem of counterfeit and substandard drugs infiltrated the system?
Widespread Problem of Adulteration
The discovery of adulterated drugs comes as no surprise in a country where the issue of food adulteration is already rampant. From milk and butter to oils and spices, the Indian market is no stranger to products laced with cheap and harmful substitutes. But the fact that even lifesaving medications are now being compromised is especially alarming.
Recent findings show that well-known medicines like Paracetamol, Telma-H, and Pantocid have been selling in markets despite failing regulatory quality checks. Pantocid, a highly popular antacid consumed by millions across India, is just one of several medications now under scrutiny for being counterfeit.
The Shocking Infiltration of Counterfeit Medicines
As part of their routine inspection, the Central Drugs Standard Control Organisation (CDSCO) has released two reports detailing the failed drugs. One of the reports includes five medications flagged as counterfeit, made to resemble authentic branded products. One such counterfeit drug is Pantocid, a widely used treatment for acidity and gas. With Indians consuming over 2,500 crore antacid pills every year, the fact that fake versions of such a common drug are circulating raises significant safety concerns.
Another troubling example is Telma-H, a medication used by those suffering from high blood pressure. Marketed under the name of a reputable pharmaceutical company, Glenmark Pharmaceuticals, counterfeit versions have made their way into the supply chain, misleading both consumers and healthcare professionals.
Authentic Drugs Also Failing the Test
Not only are counterfeit drugs a problem, but authentic branded medications have also been found lacking in quality. For instance, the much-used Paracetamol 500 MG, typically taken for fever, has failed quality tests. What was once considered a reliable treatment is now shown to be deficient in its key ingredients, leading many to question why more doses are needed to get the same effect that one pill used to provide.
This isn’t an isolated case. PAN-D, another widely prescribed drug, also failed due to discrepancies in the composition of the drug salts used. As PAN-D is manufactured by a major pharmaceutical company, Alkem Health Science, the failure of such a high-profile drug raises troubling questions about the overall regulation of pharmaceuticals in India.
The Impact on Consumer Trust
India boasts the third-largest pharmaceutical industry in the world, supplying medicines to over 200 countries. However, the issue of adulterated and low-quality medicines risks damaging the trust that millions of patients place in their treatments. When patients take a medication, they have no way of knowing its exact origins or composition—they rely solely on the government’s regulatory system to ensure its safety and effectiveness.
The bigger question is, if the medicines we depend on are failing quality tests, what does that say about the safeguards in place? This crisis affects not just the pharmaceutical industry but also the credibility of healthcare in the country.
Political Ties and Corporate Donations
Another layer to this unfolding story is the political involvement of pharmaceutical companies. Some of the manufacturers whose products failed the quality tests have been revealed to have donated significant amounts of money to political parties. For example, Torrent Pharmaceuticals, whose medicines Shelcal and Montair LC were flagged, contributed 77.5 crore rupees in electoral bonds. While it is unclear if there is any direct link between these donations and the quality of the drugs, it does raise ethical questions about the relationship between corporate interests and public health.
The fact that some pharmaceutical companies are politically connected while their products fail quality control only adds to public mistrust.
The findings of adulterated and low-quality drugs in the market have sent shockwaves through India’s healthcare system. As the country continues to grapple with the fallout, it becomes increasingly important for regulatory bodies to tighten controls and for the public to remain vigilant. In a nation that produces some of the world’s most sought-after medicines, it is essential to restore faith in the system and ensure that quality is never compromised—especially when it comes to something as critical as healthcare.
Leave a Reply